Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients

Thromb Res. 2021 Jul:203:33-35. doi: 10.1016/j.thromres.2021.04.016. Epub 2021 Apr 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / adverse effects
  • COVID-19*
  • Heparin / adverse effects
  • Humans
  • Prevalence
  • SARS-CoV-2
  • Thrombocytopenia* / chemically induced
  • Thrombocytopenia* / epidemiology

Substances

  • Anticoagulants
  • Heparin